Hyloris Pharmaceuticals
Hyloris Pharmaceuticals is a Public Limited Company registered in Belgium under 0674494151, and its current status with Crossroads Bank for Enterprises (KBO/BCE) is active. The company was incorporated on 10 April 2017 and lists its registered address as Belgium. No shareholders are recorded for Hyloris Pharmaceuticals; ownership in this jurisdiction is held as the registre des actions nominatives (register of registered shares) under the Code des sociétés et des associations, a record kept privately rather than filed publicly. No beneficial owner (UBO) data is recorded for Hyloris Pharmaceuticals; access to beneficial-ownership data in this jurisdiction is governed by its own register rules. This profile is sourced directly from Crossroads Bank for Enterprises (KBO/BCE) and was last updated on 25 September 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Officers
12
Directors and officers of Hyloris Pharmaceuticals
The Co-founder, Co-ceo & Director of Hyloris Pharmaceuticals currently on record is Stijn Van Rompay; 12 officers are currently on record for Hyloris Pharmaceuticals, filed with Crossroads Bank for Enterprises (KBO/BCE). The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
Group structure of Hyloris Pharmaceuticals
Hyloris Pharmaceuticals has no recorded parent company — it sits at the top of its own group structure, with 4 subsidiaries recorded beneath it across 1 jurisdiction. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
- Hyloris Developments (Belgium)
- Hyloris (Belgium)
- Hyloris Therapeutics (Belgium)
- Dermax (Belgium)
Data availability
Those 4 subsidiaries span Belgium jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Hyloris Pharmaceuticals
Belgium
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who is Hyloris Pharmaceuticals's UBO (Ultimate Beneficial Owner)?
No Ultimate Beneficial Owner (UBO) data is recorded for Hyloris Pharmaceuticals; access to beneficial-ownership data in this jurisdiction is governed by its own register rules.
What is Hyloris Pharmaceuticals's company registration number?
Hyloris Pharmaceuticals's registration number is 0674494151, filed with Crossroads Bank for Enterprises (KBO/BCE) in Belgium. Its current status on the register is active.
Is Hyloris Pharmaceuticals still an active company?
Hyloris Pharmaceuticals's status on Crossroads Bank for Enterprises (KBO/BCE) is listed as active.
When was Hyloris Pharmaceuticals incorporated?
Hyloris Pharmaceuticals was incorporated on 10 April 2017, according to Crossroads Bank for Enterprises (KBO/BCE).
What is Hyloris Pharmaceuticals's registered address?
The registered address on file for Hyloris Pharmaceuticals is Belgium.
What legal structure is Hyloris Pharmaceuticals registered as?
Hyloris Pharmaceuticals is registered as a Public Limited Company in Belgium.
Who are the officers/directors of Hyloris Pharmaceuticals?
The Co-founder, Co-ceo & Director of Hyloris Pharmaceuticals currently on record is Stijn Van Rompay; 12 officers are currently on record for Hyloris Pharmaceuticals, filed with Crossroads Bank for Enterprises (KBO/BCE).
Does Hyloris Pharmaceuticals have a parent company or subsidiaries?
Hyloris Pharmaceuticals has no recorded parent company — it sits at the top of its own group structure, with 4 subsidiaries recorded beneath it across 1 jurisdiction. Those 4 subsidiaries span Belgium jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Can Zavia monitor changes to Hyloris Pharmaceuticals's ownership over time?
This profile reflects a point-in-time snapshot from Crossroads Bank for Enterprises (KBO/BCE). Zavia's monitoring API can track changes to Hyloris Pharmaceuticals's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Hyloris Pharmaceuticals's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Belgium, so records like Hyloris Pharmaceuticals's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Crossroads Bank for Enterprises (KBO/BCE) and was last synced on 25 September 2026.